Orgenesis Inc.

(ORGS) Trade

Symbol has changed to a new ticker symbol

(ORGSD)

By |

Profile

Orgenesis Inc is engaged in developing clinical stage technology that with the capacity to induce a shift in developmental fate of cells from liver & converting them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes.

Contact Information

Website: www.orgenesis.com
Main Phone: +1 480 659-1020
Address: 20271 Goldenrod Lane
State: MD
City / Town: Germantown
Country: USA
Postal Code: 20876

Issuer Information

Exchange: NSC
CEO: Vered Caplan
Employees: 103
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 9.11 $ -0.11 (-1.19%)
Last Price 9.11 Change $ -0.11 Change % -1.19 Tick N/A
Bid 8.50 Bid Size 2,000.00 Ask 14.90 Ask Size 100.00
Open 9.17 High 9.17 Low 9.01 Prev Close 9.22
Last Trade Volume 9,496 52 Wk Hi 16.80 52 Wk Low 2.76
Market Cap 99.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 10,897,053.00 EPS (TTM) 0.11 PE Ratio 83.80 Exchange NCM